Efi Benmeir - SVP Finance & CFO International Markets - Teva Pharmaceutical Industries Ltd. | LinkedIn
![From left, Dan S. Suesskind, CFO, Shlomo Yanai, incoming president and CEO, Israel Makov, outgoing president and CEO, and Eli Hurvitz, chairman of the board of Teva Pharmaceutical Industries, Ltd. take part From left, Dan S. Suesskind, CFO, Shlomo Yanai, incoming president and CEO, Israel Makov, outgoing president and CEO, and Eli Hurvitz, chairman of the board of Teva Pharmaceutical Industries, Ltd. take part](https://c8.alamy.com/comp/TYHXY6/from-left-dan-s-suesskind-cfo-shlomo-yanai-incoming-president-and-ceo-israel-makov-outgoing-president-and-ceo-and-eli-hurvitz-chairman-of-the-board-of-teva-pharmaceutical-industries-ltd-take-part-in-the-opening-bell-ceremonies-at-the-nasdaq-in-new-york-on-february-21-2007-upi-photolaura-cavanaugh-TYHXY6.jpg)
From left, Dan S. Suesskind, CFO, Shlomo Yanai, incoming president and CEO, Israel Makov, outgoing president and CEO, and Eli Hurvitz, chairman of the board of Teva Pharmaceutical Industries, Ltd. take part
![Having cut Teva's manufacturing headcount by thousands, Carlo de Notaristefani will retire | Fierce Pharma Having cut Teva's manufacturing headcount by thousands, Carlo de Notaristefani will retire | Fierce Pharma](https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1570024771/Teva%20Carlo%20De%20Notaristefani.jpg?VersionId=lWi7Q3KP9bzL2EZ57HUuJpjAPF0tatpN)
Having cut Teva's manufacturing headcount by thousands, Carlo de Notaristefani will retire | Fierce Pharma
![From left, Dan S. Suesskind, CFO, Shlomo Yanai, incoming president and CEO, Israel Makov, outgoing president and CEO, and Eli Hurvitz, chairman of the board of Teva Pharmaceutical Industries, Ltd. take part From left, Dan S. Suesskind, CFO, Shlomo Yanai, incoming president and CEO, Israel Makov, outgoing president and CEO, and Eli Hurvitz, chairman of the board of Teva Pharmaceutical Industries, Ltd. take part](https://c8.alamy.com/comp/TYHXY2/from-left-dan-s-suesskind-cfo-shlomo-yanai-incoming-president-and-ceo-israel-makov-outgoing-president-and-ceo-and-eli-hurvitz-chairman-of-the-board-of-teva-pharmaceutical-industries-ltd-take-part-in-the-opening-bell-ceremonies-at-the-nasdaq-in-new-york-on-february-21-2007-upi-photolaura-cavanaugh-TYHXY2.jpg)
From left, Dan S. Suesskind, CFO, Shlomo Yanai, incoming president and CEO, Israel Makov, outgoing president and CEO, and Eli Hurvitz, chairman of the board of Teva Pharmaceutical Industries, Ltd. take part
![From left, Dan S. Suesskind, CFO, Shlomo Yanai, incoming president and CEO, Israel Makov, outgoing president and CEO, and Eli Hurvitz, chairman of the board of Teva Pharmaceutical Industries, Ltd. take part From left, Dan S. Suesskind, CFO, Shlomo Yanai, incoming president and CEO, Israel Makov, outgoing president and CEO, and Eli Hurvitz, chairman of the board of Teva Pharmaceutical Industries, Ltd. take part](https://c8.alamy.com/comp/TYHXY9/from-left-dan-s-suesskind-cfo-shlomo-yanai-incoming-president-and-ceo-israel-makov-outgoing-president-and-ceo-and-eli-hurvitz-chairman-of-the-board-of-teva-pharmaceutical-industries-ltd-take-part-in-the-opening-bell-ceremonies-at-the-nasdaq-in-new-york-on-february-21-2007-upi-photolaura-cavanaugh-TYHXY9.jpg)